Avandia, made by pharmaceutical company Glaxo Smith Kline (
GSK), was approved by the EMA in 2000 to help lower blood sugar levels in patients with Type 2 diabetes.
GSK has maintained that its extensive research involving over 50,000 patients has shown that Avandia does not increase the overall risk of heart attack, stroke or death compared to other diabetes drugs.